Autolus Therapeutics AUTL Cash Flow Statement (2017-2026)

NASDAQ AUTL
$1.62 -0.04 (-2.41%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Autolus Therapeutics Quarterly Cash Flow Statement

Periods 34 quarters
Latest Jun 2026

Autolus Therapeutics cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 34 quarters of results from Sep 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2017 Dec2017 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-33.20M-34.00M-41.67M-37.06M-42.06M-42.77M-26.94M-39.81M-45.60M-45.85M-77.19M-52.69M-58.30M-82.10M-27.60M-70.16M-47.92M-79.12M-90.33M-39.11M
Depreciation and DepletionDep. & Depletion
2.20M2.40M2.10M2.00M1.90M1.80M1.60M1.90M1.50M1.40M1.80M1.80M1.90M1.90M2.00M2.00M2.10M2.10M2.10M2.20M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.20M0.30M0.30M0.50M0.49M0.50M
Depreciation & Amortization (CF)Dep. & Amort.
2.24M2.45M2.10M2.07M1.92M1.79M1.65M1.90M1.51M1.38M1.78M1.81M1.90M1.94M1.92M1.99M2.08M2.08M2.14M2.20M
Share-based CompensationStock Comp.
1.28M1.50M7.83M2.34M2.92M3.34M3.42M2.41M2.66M2.86M3.28M2.28M2.94M4.02M6.23M2.87M4.29M3.84M3.44M
Deferred Taxes
0.40M0.23M-0.42M-0.17M-0.25M-0.16M0.32M-0.20M-0.09M-0.24M-0.47M-0.23M0.07M-0.17M0.14M0.49M0.38M0.01M-1.17M
Gains from Sales and DivestituresGains Divest
-0.52M-3.79M-0.02M0.02M-0.22M0.00M-0.01M
Asset Writedowns and ImpairmentWritedown
0.38M0.02M0.41M2.50M4.30M4.70M1.20M
Other non-cash itemsOther Non-Cash
0.00M3.72M5.24M5.30M-3.11M-1.96M-2.33M6.99M-6.14M2.81M0.62M-12.94M16.30M-0.84M-2.92M4.04M-9.19M
Change in Working Capital
Change in ReceivablesChange Receivables
14.34M12.39M6.00M-8.57M
Change in InventoryChange Inventory
4.23M10.10M11.44M8.60M10.11M
Change in Account PayablesChange Payables
-2.37M0.50M-1.03M-0.27M-0.05M0.23M0.11M-0.23M3.49M-3.19M-0.58M1.32M-0.34M0.28M0.33M1.86M1.53M5.42M-7.52M
Change in Other Operating AssetsOther Assets Change
1.54M15.07M-28.24M5.25M4.59M10.67M-9.71M4.04M-4.32M5.06M-18.14M10.11M6.67M4.79M11.02M-0.73M-0.03M13.99M-8.67M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.84M2.48M-4.12M-0.36M0.02M-0.13M-4.22M-2.13M-4.67M-5.17M-1.59M-1.18M-1.42M-1.48M3.71M7.97M0.76M8.11M-2.20M
Other Working Capital ChangesOther WC Changes
-2.37M-12.59M24.12M-5.61M-4.57M-10.80M5.49M-6.17M-0.35M-10.23M16.55M-11.29M-8.08M-6.26M-7.31M8.70M0.79M-5.88M6.47M
Cash from OperationsCash from Ops.
-36.61M-34.75M-9.16M-35.03M-30.81M-31.90M-14.57M-42.42M-38.15M-40.19M-24.83M-40.51M-51.08M-76.74M-37.93M-75.57M-72.78M-67.90M-67.32M
Investing Activities
Capital ExpendituresCapex
1.51M3.86M1.59M0.77M2.64M6.80M0.63M3.62M4.39M1.50M1.48M0.53M0.84M9.59M11.11M8.24M7.28M4.41M-0.89M
Change in Property, Plant and EquipmentChange in PP&E
-1.51M-3.86M-1.59M-0.77M-2.64M-6.80M-0.63M-3.62M-4.39M-1.50M-1.48M-0.53M-0.84M-9.59M-11.11M-8.24M-7.28M-4.41M0.89M
Change in IntangiblesChange Intangibless
12.74M
Purchase of InvestmentsInvestments Purchased
359.73M71.30M48.00M82.94M40.38M
Sale and Maturity of InvestmentsInvestments Sold
20.00M151.19M130.98M126.04M
Cash from Investing ActivitiesCash from Investing
-1.51M-3.86M-1.59M-0.77M-2.64M-6.80M-0.63M-3.62M-4.39M-1.50M-1.48M-0.53M-0.84M-9.59M-383.59M-59.55M95.92M35.55M86.54M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
5.98M-0.23M109.38M0.12M163.85M0.00M0.02M550.26M0.13M0.19M0.01M
Net Shares Issued and RepurchasedNet Shares Issued
5.98M-0.23M109.38M0.12M163.85M0.00M0.02M550.26M0.13M0.19M0.01M
Net Equity Issued and RepurchasedNet Equity Issued
5.98M-0.23M109.38M0.12M163.85M0.00M0.02M550.26M0.13M0.19M0.01M
Other financing activitiesOther financing
7.57M-11.45M0.00M-0.02M-10.35M-0.69M-0.22M-27.52M-1.84M
Cash from Financing ActivitiesCash from Financing
13.55M-0.23M147.42M0.00M0.10M223.51M-0.69M-0.22M0.00M0.02M561.44M-2.08M0.19M30.01M-0.77M-1.77M-1.80M
Additional items
Exchange Rate EffectFX Effect
1.33M-4.45M0.73M-5.98M-18.68M-14.80M11.08M7.33M7.23M-9.30M9.77M-1.19M1.42M37.72M-38.22M3.56M5.72M-3.58M0.59M
Change in Cash
-23.24M-43.29M137.41M-41.78M-52.13M-53.39M219.39M-39.41M-35.52M-50.98M-16.51M519.21M-52.59M-48.42M-429.73M-131.55M28.08M-37.71M18.01M
Ending Cash Balance
216.56M173.27M310.68M268.56M216.44M163.05M382.76M343.36M307.83M256.85M240.34M759.54M706.96M658.54M228.81M97.25M125.33M87.62M105.64M172.91M
Free Cash FlowFCF
-38.12M-38.61M-10.74M-35.80M-33.45M-38.70M-15.20M-46.04M-42.54M-41.69M-26.31M-41.05M-51.92M-86.33M-49.05M-83.81M-80.06M-72.31M-66.44M
Net Cash FlowNCF
-24.57M-38.84M136.67M-35.80M-33.45M-38.60M208.31M-46.73M-42.76M-41.68M-26.29M520.39M-54.00M-86.14M-391.52M-135.11M22.37M-34.13M17.42M
Income Taxes PaidTaxes Paid
-0.27M0.55M0.98M0.28M1.13M0.01M1.03M0.50M0.43M

Autolus Therapeutics Cash Flow Statement API

Pull Autolus Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=AUTL&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY